// App-Quantinova.ai

BS33 : Candesartan prevents cisplatin-induced vascular toxicity by attenuating oxidative stress, inflammation, and necroptosis and upregulating NRF2/HO-1 signaling in RAT AORTA

Researchers

Presenter

  • Ayman Mahmoud

Principal Investigators

  • Emad Hassanein

Medical Centers

  • Manchester Metropolitan University, John Dalton Building, All Saints Campus Manchester, MAN M GD United Kingdom, UK

  • Al-Azhar University

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Heme oxygenase 1 deficiency

Biomarkers

  • Heme oxygenase-1

Drug/Treatment

  • candesartan (tablet)

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved